InMed Pharmaceuticals Inc. — Form 4
Filed September 16, 2026 · analyzed by the Insider Agent
4
▲ Likely positive
significance 52/100
What the filing says
10% owner ADAR1 Capital Management, LLC (INM) bought 91K shares (~$118K) on the open market (9.3% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating
Open-market insider purchase — historically a bullish signal.
See more from September 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.